Matthew R. Plooster, Director at ZEVRA THERAPEUTICS, INC. (ZVRA), bought 11,000 shares at $4.20 ($46K) on 2023-03-09, disclosed to the SEC on 2023-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.